AngioDynamics (FRA:UG2) Beta: 0.8138 (As of Jun. 24, 2026)


FRA:UG2 AngioDynamics Inc FRA:UG2
62 GF Score
Price €10.80
GF Value €7.27
! 7 Warning Signs
View Full Analysis

What is AngioDynamics Beta?

AngioDynamics FRA:UG2 -0.92% 62 Beta is 0.8138 as of Jun. 24, 2026. GuruFocus rates FRA:UG2 with a GF Score™ of 62/100 and a GF Value™ of €7.27. The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), AngioDynamics's Beta is 0.8138.


AngioDynamics  (FRA:UG2) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


AngioDynamics Beta Related Terms


AngioDynamics Beta Historical Data

* Premium members only.

The historical data trend for AngioDynamics's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioDynamics Beta Chart

AngioDynamics Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.02 1.31 0.97 0.52 0.43

AngioDynamics Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.43 0.44 1.02 0.77

FRA:UG2 vs OSUR, UTMD, SMTI: Beta Comparison

For the Medical Instruments & Supplies subindustry, AngioDynamics's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AngioDynamics Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's Beta distribution charts can be found below:

* The bar in red indicates where AngioDynamics's Beta falls into.


FRA:UG2
62GF Score
AngioDynamics Inc FRA:UG2
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AngioDynamics Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.8138 mean?
AngioDynamics (FRA:UG2) has a Beta of 0.8138 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for AngioDynamics and its competitors.
Is AngioDynamics' Beta too high?
AngioDynamics' current Beta is 0.8138. Overall, AngioDynamics has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does AngioDynamics' Beta compare to OSUR and UTMD?
AngioDynamics' Beta of 0.8138 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for AngioDynamics and its competitors. AngioDynamics's current Beta is 0.8138. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AngioDynamics stock overvalued right now?
AngioDynamics (FRA:UG2) has a current Beta of 0.8138. The stock's GF Value™ is €7.27, compared to a current price of €10.80 — trading 48.6% above its estimated fair value. The current Beta is 0.8138. AngioDynamics' overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For AngioDynamics (FRA:UG2), the current Beta is 0.8138 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AngioDynamics (FRA:UG2) Overvalued in 2026?

Based on GuruFocus' analysis, AngioDynamics stock appears to be overvalued. The current stock price of €10.80 is trading 48.6% above its estimated GF Value™ of €7.27.

Key valuation signals for FRA:UG2:

  • Beta: 0.8138
  • GF Value™: €7.27 vs. price of €10.80 (48.6% above fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the FRA:UG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AngioDynamics Business Description

Other Exchanges ANGO:USA
Address 14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
62GF Score

Get the complete analysis for FRA:UG2

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.80
Price
€7.27
GF Value